Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#376 most reported symptom for this vaccine
Lymphocyte percentage decreased has been reported 39 times in association with Meningococcal Conjugate (Menactra) vaccination in VAERS. This represents 0.1% of all 36,149 reports for this vaccine.
Among these reports, 1 mentioned death (2.56%) and 25 involved hospitalization (64.1%).
Lymphocyte percentage decreased is the #376 most frequently reported symptom for Meningococcal Conjugate (Menactra) out of 1843 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 39 reports of Lymphocyte percentage decreased after Meningococcal Conjugate (Menactra) vaccination may seem alarming, but context is critical.
The mortality rate of 2.56% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.